Quipt Home Medical Corp. (NASDAQ:QIPT - Get Free Report) saw a large increase in short interest in December. As of December 15th, there was short interest totalling 1,050,000 shares, an increase of 19.3% from the November 30th total of 880,100 shares. Based on an average daily volume of 167,800 shares, the short-interest ratio is currently 6.3 days. Approximately 2.7% of the company's stock are short sold.
Quipt Home Medical Stock Up 8.9 %
NASDAQ:QIPT traded up $0.25 during mid-day trading on Tuesday, reaching $3.05. The stock had a trading volume of 543,839 shares, compared to its average volume of 196,083. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.11 and a quick ratio of 0.77. The company has a market capitalization of $131.43 million, a price-to-earnings ratio of -27.73 and a beta of 0.62. Quipt Home Medical has a 1-year low of $2.30 and a 1-year high of $5.26. The stock's 50 day simple moving average is $2.63 and its two-hundred day simple moving average is $2.91.
Quipt Home Medical (NASDAQ:QIPT - Get Free Report) last posted its quarterly earnings results on Monday, December 16th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.01 by ($0.08). Quipt Home Medical had a negative return on equity of 4.51% and a negative net margin of 1.95%. Equities analysts anticipate that Quipt Home Medical will post -0.1 EPS for the current year.
Insider Buying and Selling at Quipt Home Medical
In related news, VP Patrick Dennis Gamble acquired 17,000 shares of the firm's stock in a transaction on Thursday, December 26th. The stock was bought at an average cost of $2.45 per share, with a total value of $41,650.00. Following the acquisition, the vice president now directly owns 40,057 shares in the company, valued at approximately $98,139.65. The trade was a 73.73 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 4.20% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Quipt Home Medical
A number of hedge funds have recently added to or reduced their stakes in QIPT. Forager Capital Management LLC increased its holdings in shares of Quipt Home Medical by 77.7% in the 3rd quarter. Forager Capital Management LLC now owns 4,192,562 shares of the company's stock worth $12,200,000 after acquiring an additional 1,833,590 shares during the period. Royce & Associates LP increased its stake in shares of Quipt Home Medical by 15.8% in the third quarter. Royce & Associates LP now owns 1,768,789 shares of the company's stock valued at $5,165,000 after purchasing an additional 240,980 shares during the period. Verition Fund Management LLC raised its holdings in shares of Quipt Home Medical by 207.5% during the third quarter. Verition Fund Management LLC now owns 78,950 shares of the company's stock valued at $231,000 after buying an additional 53,275 shares during the last quarter. Rhumbline Advisers boosted its position in shares of Quipt Home Medical by 21.0% during the second quarter. Rhumbline Advisers now owns 49,276 shares of the company's stock worth $159,000 after buying an additional 8,541 shares during the period. Finally, Bank of New York Mellon Corp grew its holdings in Quipt Home Medical by 32.8% in the 2nd quarter. Bank of New York Mellon Corp now owns 129,738 shares of the company's stock worth $418,000 after buying an additional 32,073 shares in the last quarter. 42.85% of the stock is currently owned by institutional investors.
About Quipt Home Medical
(
Get Free Report)
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.
Recommended Stories
Before you consider Quipt Home Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quipt Home Medical wasn't on the list.
While Quipt Home Medical currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.